Yes-associated protein is not an independent prognostic marker in breast cancer

Anticancer Research

Volumn 32, Issue 8, 2012, Pages 3321-3326

  Sheen Chen, Shyr Ming ^a   Huang, Chun Ying ^a   Tsai, Ching Hua ^a   Liu, Yueh Wei ^a   Wu, Shih Chung ^a   Huang, Chao Cheng ^a   Eng, Hock Liew ^a   Chan, Yi Chia ^a   Ko, Sheung Fat ^a   Tang, Rei Ping ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Breast cancer; Tissue microarray; Yes assosiated protein

Indexed keywords

ESTROGEN RECEPTOR; PROTEIN KINASE YES;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NUCLEAR PROTEINS; PROGNOSIS; SURVIVAL RATE; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84865701871     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000.
2. Brunner T and Mueller C: Apoptosis in disease: about shortage and excess. Essays Biochem 39: 119-130, 2003.
3. Lai ZC, Wei X, Shimizu T, Ramos E, Rohrbaugh M, Nikolaidis N, Ho LL and Li Y: Control of cell proliferation and apoptosis by mob as tumor suppressor, mats. Cell 120: 675-685, 2005.
4. Olson MF: Modeling human cancer: report on the eight Beatson International Cancer Conference. Cancer Res 65: 11247-11250, 2005.
5. Edgar BA: From cell structure to transcription: Hippo forges a new path. Cell 124: 267-273, 2006.
6. Pan D: Hippo signaling in organ size control. Gene Dev 21: 886-897, 2007.
7. Yagi R, Chen LF, Shigesada K, Murakami Y and Ito Y: A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. EMBO 18: 2551-2562, 1999.
8. Sudol M: Yes-associated protein (YAP 65) is a proline-rich phosphoprotein that birds to the SH3 domain of the yes protooncogene product. Oncogene 9(8): 2145-2152, 1994.
9. Li Z, Zhao B, Wang P, Chen F, Dong Z, Yang H, Guan KL, Xu Y: Structural insights into the YAP and TEAD complex. Genes Dev 24: 235-240, 2010.
10. Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, Gayyed mf, Anders RA, Maitra A and Pan D: Elucidation of a universal size control mechanism in Drosophila and mammals. Cell 130: 1120-1133, 2007.
11. Andre F, Job B, Dessen P, Tordai A, Michiels S, Liedtke C, Richon C, Yan K, Wang B, Vassal G, Delaloge S, Hortobagyi GN, Symmans WF, Lazar V and Pusztai L: Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array. Clin Cancer Res 15: 441-451, 2009.
12. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lønning PE, Børresen-Dale AL, Brown PO and Botstein D: Molecular portraits of human breast tumors. Nature 406: 747-752, 2000.
13. Sotiriou C and Pustai L: Gene-expression signatures in breast cancer. N Engl J Med 360: 790-800, 2009.
14. Sortiriou C, Neo SY and McShane LM: Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad USA 100: 8418-8423, 2003.
15. Mook S, Schmidt MK and Rutger EJ: Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant program: a hospital-based retrospective cohort study. Lancet Oncol 10: 1070-1076, 2009.
16. Torhorst J, Bucher C and Kononen J: Tissue microarray for rapid linking of molecular changes to clinical endpoints. Am J Pathol 159: 2249-2256, 2001.
17. Schmidt LH, Biesterfeld S, Kummel A, Faldum A, Sebastian M, Taube C, Buhll R and Wiewrodt R: Tissue microarray are reliable tools for the clinicopathologic characterization of lung cancer tissue. Anticancer Res 29: 201-209, 2009.
18. The World Health Organization Histological Typing of Breast Tumor, 2nd ed. Am J Clin Pathol 78: 808-816, 1982.
19. Shyr-Ming Sheen-Chen, Wei-Jen Chen, Hock-Liew Eng and Fong-Fu Chou: Serum concentration of tumor necrosis factor in patients with breast cancer. Breast Cancer Res Treat 43: 211-215, 1997.
20. Shyr-Ming Sheen-Chen, Hock-Liew Eng, Fong-Fu Chou, Wei-Jen Chen: The prognostic significance of proliferating cell nuclear antigen in patients with lymph node-positive breast cancer. Arch Surg 132: 264-267, 1997.
21. Shyr-Ming Sheen-Chen, Wei-Jen Chen, Hock-Liew Eng and Fong-Fu Chou: Serum-soluble interleukin-2 receptor concentrations in patients with breast cancer: A preliminary report. Chang Gung Med J 21: 133-138, 1998.
22. Shyr-Ming Sheen-Chen, Fong-Fu Chou, Hock-Liew Eng and Wei-Jen Chen: An evaluation of the prognostic significance of HLA -DR expression in axillary node-negative breast cancer. Surgery 116: 510-515, 1994.
23. Perrone EE, Theoharis C, Mucci NR, Hayasaka S, Taylor Jeremy MG, Cooney KA and Rubin MA: Tissue microarray assessment of prostate cancer tumor proliferation in African-American and white men. J Natl Cancer Inst 92(11): 937-939, 2000.
24. Morin-Kensicki EM, Boone BN, Howell M, Stonebraker JR, Teed J, Alb JG, Magnuson TR, O'Neal W and Milgram SL: Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of YAP65. Mol Cell Biol 26: 77-87, 2006.
25. Steinhardt AA, Gayyed MF, Klein AP, Dong J, Maitra A, Pan D, Montgomery EA and Anders RA: Expression of yes-associated protein in common solid tumors. Human Pathology 39: 1582-1589, 2008.
26. Chan SW, Lim CJ, Chen L, Chong YF, Huang C, Song H, Hong W: The hippo pathway in biological control and cancer development. J Cell Physiol 226: 928-939, 2011.
27. Mengel M, Kreipe H, Von Wasielewski R: Rapid and large-scale transition of new tumor biomarkers to clinical biopsy material by innovative tissue microarray systems. Appl Immmunohistochem Mol Morphol 11: 261-268, 2003.
28. Schraml P, Kononen J, Bubendorf L, Moch H, Bissig H, Nocito A, Mihatsch MJ, Kallioniemi OP and Sauter G: Tissue microarrays for gene amplication surveys in many different tumor types. Clin Cancer Res 5: 1966-1975, 1999.
29. Kononen J, Bubendorf L, Kallioniemi A, Bärlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G and Kallionimeni OP: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844-847, 1998.
30. Moch H, Kononen J, Kallioniemi OP and Sauter G: Tissue microarrays: what will they bring to molecular and anatomic pathology? Adv Anat Pathol 8: 14-20, 2001.
31. Rijn MVD and Gilks CB: Applications of microarrays to histopathology. Histopathology 44: 97-108, 2004.
32. Zhang D, Salto-Tellez M, Putti TC, Do E and Koay ES: Reliability of tissue microarray in detecting protein expression and gene amplification in breast cancer. Mod Pathol 16: 79-84, 2003.